Literature DB >> 8653985

Loss of elbow and wrist motion in hemophilia.

J G Gamble1, H Vallier, M Rossi, B Glader.   

Abstract

The longitudinal changes in elbow and wrist motion for 48 patients with hemophilia were reviewed to determine the effect of recurrent hemarthroses. The average age of the patients at the time of followup was 23 years 9 months. The average duration of followup was 10.8 years. The patients were divided into 3 age groups: younger than age 15 years (14 patients), age 15 to 25 years (11 patients), and older than age 25 years (23 patients). For patients older than age 25 years, pronation, supination, elbow flexion and extension, wrist flexion and extension, and ulnar deviation were significantly decreased relative to patients younger than age 15 years. Pronation was the first motion to show a significant change, decreasing by 19% in patients age 15 to 25 years and by 31% in patients older than age 25 years. Loss of elbow extension showed the greatest change. In cases of severe hemophilic arthropathy of the elbow, synovectomy and radial head excision decreased elbow pain and bleeding episodes and improved supination and pronation.

Entities:  

Mesh:

Year:  1996        PMID: 8653985     DOI: 10.1097/00003086-199607000-00017

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  [Orthopedic interventions in patients with hemophilia].

Authors:  Joannis Panotopoulos; Klemens Trieb
Journal:  Wien Med Wochenschr       Date:  2003

2.  Functional disability in children with hemophilic arthropathy.

Authors:  Eda Gurcay; Emel Eksioglu; Ustun Ezer; Reyhan Tuncay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2006-02-17       Impact factor: 2.631

3.  Manual and educational therapy in the treatment of hemophilic arthropathy of the elbow: a randomized pilot study.

Authors:  Rubén Cuesta-Barriuso; Antonia Gómez-Conesa; José-Antonio López-Pina
Journal:  Orphanet J Rare Dis       Date:  2018-09-03       Impact factor: 4.123

4.  Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant).

Authors:  Hitoshi Ueda; Misato Toyoda; Morio Arai; Michio Sakai
Journal:  Int J Gen Med       Date:  2020-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.